| Literature DB >> 29951594 |
Kelsey Gabel1, Kristin K Hoddy1, Nicole Haggerty1, Jeehee Song1, Cynthia M Kroeger1,2, John F Trepanowski1, Satchidananda Panda3, Krista A Varady1.
Abstract
BACKGROUND: Time restricted feeding decreases energy intake without calorie counting and may be a viable option for weight loss. However, the effect of this diet on body weight in obese subjects has never been examined.Entities:
Keywords: Time restricted feeding; body weight; intermittent fasting; metabolic disease risk factors; obese adults
Year: 2018 PMID: 29951594 PMCID: PMC6004924 DOI: 10.3233/NHA-170036
Source DB: PubMed Journal: Nutr Healthy Aging
Fig.1Study flow chart.
Baseline characteristics1
| Time restricted feeding | Control | ||
| N | 23 | 23 | |
| Age (y) | 50 ± 2 | 48 ± 2 | 0.43 |
| Sex (F/M) | 20/3 | 21/2 | 0.82 |
| Ethnicity | 0.69 | ||
| African American | 17 | 17 | |
| Caucasian | 3 | 5 | |
| Hispanic | 3 | 1 | |
| Weight (kg) | 95 ± 3 | 92 ± 3 | 0.34 |
| Height (m) | 1.66 ± 0.02 | 1.63 ± 0.01 | 0.29 |
| BMI (kg/m2) | 35 ± 1 | 34 ± 1 | 0.61 |
1All values reported as mean ± SEM. 2 P values for comparison of baseline variables between groups using independent samples t-test (continuous variables) and the McNemar test (categorical variables).
Fig.2Weekly adherence to the 8-hour feeding window by the time restricted feeding group. All values reported as mean ± SEM. Each bar indicates the mean number of days per week that the time restricted feeding subjects were compliant with the 8-hour feeding window. On average, the time restricted feeding group was compliant with the prescribed eating window (10:00 to 18:00 h) on 5.6 ± 0.3 d/week, and this level of adherence did not change over the course of the trial (P = 0.86, repeated measures ANOVA).
Self-reported dietary intake, eating duration, and physical activity at baseline and week 12 1
| Time restricted feeding ( | Control ( | ||||
| Baseline 2 | Week 12 | Baseline 2 | Week 12 | ||
| Energy (kcal) | 1676 ± 114 | 1335 ± 162 | 1645 ± 113 | 1654 ± 191 |
|
| Protein (% ) | 16 ± 1 | 17 ± 1 | 17 ± 1 | 17 ± 1 | 0.40 |
| Carbohydrates (% ) | 47 ± 2 | 46 ± 2 | 46 ± 2 | 45 ± 2 | 0.61 |
| Fat (% ) | 37 ± 1 | 37 ± 2 | 37 ± 1 | 38 ± 2 | 0.74 |
| Cholesterol (mg) | 279 ± 24 | 214 ± 27 | 275 ± 27 | 265 ± 37 | 0.32 |
| Fiber (g) | 16 ± 2 | 13 ± 1 | 14 ± 1 | 15 ± 2 | 0.17 |
| Daily eating duration (h) | 11 ± 1 | 8 ± 1 | 11 ± 1 | 11 ± 1 |
|
| Start of eating duration (local time, h) | 8:30 ± 0:30 | 10:00 ± 0:30 | 9:30 ± 0:30 | 8:30 ± 0:30 |
|
| End of eating duration (local time, h) | 19:30 ± 0:30 | 18:00 ± 0:30 | 20:30 ± 0:30 | 19:30 ± 0:30 | 0.32 |
| Steps/day | 6896 ± 723 | 7443 ± 880 | 6148 ± 775 | 6967 ± 584 | 0.84 |
1 All values reported as mean ± SEM. Data for all variables were collected over a 7-d period at baseline (prior to the commencement of the study) and week 12 in the TRF and control groups. Data were included for 46 participants; means were estimated using an intention-to-treat analysis using last observation carried forward. 2Baseline variables: No difference between groups for any parameter (Independent samples t-test). 3 P values reported for the time restricted feeding group relative to the control group (group×time interaction) using repeated-measures 2-factor ANOVA.
Fig.3Weight loss by the time restricted feeding group versus controls 1. 1All values reported as mean ± SEM. Data were included for 46 participants; means were estimated using an intention-to-treat analysis using last observation carried forward. Body weight remained stable during the 2-week baseline period (week B1 and week B2). Body weight decreased in the time restricted feeding group relative to controls during the 12-week intervention period (P < 0.001 for time × group interaction).
Body composition and metabolic disease risk factors after 12 weeks1
| Time restricted feeding ( | Control ( |
| |||
| Baseline2 | Week 12 | Baseline2 | Week 12 | ||
| Body weight (kg) | 95 ± 3 | 92 ± 3 | 92 ± 3 | 92 ± 3 |
|
| Fat mass (kg)4 | 42 ± 2 | 40 ± 2 | 37 ± 2 | 37 ± 2 | 0.23 |
| Lean mass (kg) | 50 ± 2 | 50 ± 2 | 53 ± 2 | 53 ± 2 | 0.12 |
| Visceral fat mass (kg) | 1.2 ± 0.1 | 1.1 ± 0.1 | 1.2 ± 0.2 | 1.2 ± 0.2 | 0.19 |
| BMI (kg/m2) | 35 ± 1 | 34 ± 1 | 34 ± 1 | 34 ± 1 |
|
| Systolic blood pressure (mm Hg) | 128 ± 4 | 121 ± 3 | 123 ± 4 | 124 ± 3 |
|
| Diastolic blood pressure (mm Hg) | 83 ± 2 | 82 ± 2 | 81 ± 2 | 82 ± 2 | 0.41 |
| Heart rate (bpm) | 69 ± 2 | 71 ± 2 | 73 ± 2 | 73 ± 3 | 0.33 |
| Total cholesterol (mg/dl) | 177 ± 7 | 178 ± 9 | 192 ± 7 | 185 ± 7 | 0.15 |
| LDL cholesterol (mg/dl) | 108 ± 5 | 110 ± 7 | 114 ± 7 | 112 ± 6 | 0.54 |
| HDL cholesterol (mg/dl) | 48 ± 2 | 49 ± 2 | 61 ± 3 | 55 ± 2 | 0.11 |
| Triglycerides (mg/dl)4 | 105 ± 11 | 93 ± 9 | 89 ± 7 | 89 ± 11 | 0.43 |
| Fasting glucose (mg/dl) | 79 ± 4 | 82 ± 2 | 87 ± 2 | 87 ± 2 | 0.77 |
| Fasting insulin (uIU/ml)4 | 8.3 ± 1.0 | 5.7 ± 0.7 | 9.2 ± 1.4 | 10.3 ± 1.9 | 0.16 |
| HOMA-IR4 | 1.6 ± 0.2 | 1.0 ± 0.2 | 2.0 ± 0.3 | 2.2 ± 0.4 | 0.21 |
| Homocysteine ( | 9.9 ± 0.6 | 9.0 ± 0.5 | 10.1 ± 0.5 | 9.4 ± 0.5 | 0.83 |
1All values reported as mean ± SEM. Data were included for 46 participants; means were estimated using an intention-to-treat analysis using last observation carried forward. HOMA-IR: Homeostatic model assessment Insulin resistance; RMR: Resting metabolic rate. 2Baseline variables: No difference between groups for any parameter (Independent samples t-test). 3 P values reported for the time restricted feeding group relative to the control group (group×time interaction) using repeated-measures 2-factor ANOVA. 4Significant main effect of time, P < 0.05.